Table 1 Mapping of study characteristics of all studies included in this review
From: The psychosocial adaptation of patients with skin disease: a scoping review
Study characteristics (N = 69) | N (%) |
|---|---|
Publication years | |
 2009–2013 | 16 (23.19) |
 2014-June 2018 | 53 (76.81) |
Country of origin | |
 UK | 8 (11.59) |
 USA | 8 (11.59) |
 Poland | 8 (11.59) |
 India | 6 (8.70) |
 German | 5 (7.25) |
 China | 4 (5.80) |
 Japan | 4 (5.80) |
 Denmark | 2 (2.90) |
 Korea | 2 (2.90) |
 Italy | 2 (2.90) |
 Greece | 2 (2.90) |
 Malaysia | 2 (2.90) |
 Canada | 2 (2.90) |
 Spain | 2 (2.90) |
 Singapore | 2 (2.90) |
 Portugal | 2 (2.90) |
 Sweden | 2 (2.90) |
 Netherlands | 1 (1.45) |
 Turkey | 1 (1.45) |
 Iran | 1 (1.45) |
 Finland | 1 (1.45) |
 Ireland | 1 (1.45) |
 Egypt | 1 (1.45) |
Study types | |
 Cross-sectional study | 43 (62.32) |
 Randomized controlled trial | 5 (7.25) |
 Review | 5 (7.25) |
 Systematic review | 3 (4.35) |
 Case-control study | 2 (2.90) |
 Prospective cross-sectional study | 2 (2.90) |
 Case series study | 2 (2.90) |
 Experimental design | 2 (2.90) |
 Qualitative study | 2 (2.90) |
 Letter | 2 (2.90) |
 Develop a rating scale | 1 (1.45) |
Study population | |
 Psoriasis | 44 (63.77) |
 Atopic dermatitis | 10 (14.49) |
 Vitiligo | 9 (13.04) |
 Eczema | 3 (4.35) |
 Skin disease | 3 (4.35) |